Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
J Med Genet. 2019 Jul;56(7):481-490. doi: 10.1136/jmedgenet-2018-105669. Epub 2019 Mar 20.
Mapping the genetic component of molecular mechanisms responsible for the reduced penetrance (RP) of rare disorders constitutes one of the most challenging problems in human genetics. Heritable pulmonary arterial hypertension (PAH) is one such disorder characterised by rare mutations mostly occurring in the bone morphogenetic protein receptor type 2 () gene and a wide heterogeneity of penetrance modifier mechanisms. Here, we analyse 32 genotyped individuals from a large Iberian family of 65 members, including 22 carriers of the pathogenic mutation c.1472G>A (p.Arg491Gln), 8 of them diagnosed with PAH by right-heart catheterisation, leading to an RP rate of 36.4%.
We performed a linkage analysis on the genotyping data to search for genetic modifiers of penetrance. Using functional genomics data, we characterised the candidate region identified by linkage analysis. We also predicted the haplotype segregation within the family.
We identified a candidate chromosome region in 2q24.3, 38 Mb upstream from , with significant linkage (LOD=4.09) under a PAH susceptibility model. This region contains common variants associated with vascular aetiology and shows functional evidence that the putative genetic modifier is located in the upstream distal promoter of the fidgetin () gene.
Our results suggest that the genetic modifier acts through transcriptional regulation, whose expression variability would contribute to modulating heritable PAH. This finding may help to advance our understanding of RP in PAH across families sharing the p.Arg491Gln pathogenic mutation in .
绘制导致罕见疾病外显率降低(RP)的分子机制的遗传成分图谱是人类遗传学中最具挑战性的问题之一。遗传性肺动脉高压(PAH)就是这样一种疾病,其特征是罕见的突变,这些突变主要发生在骨形态发生蛋白受体 2 型(BMPR2)基因中,并且存在广泛的外显率修饰机制异质性。在这里,我们分析了一个由 65 名成员组成的大型伊比利亚家族中的 32 名基因分型个体,其中包括 22 名携带致病性突变 c.1472G>A(p.Arg491Gln)的携带者,其中 8 名被右心导管检查诊断为 PAH,导致外显率为 36.4%。
我们对基因分型数据进行连锁分析,以寻找外显率的遗传修饰因子。我们使用功能基因组学数据来描述连锁分析中确定的候选区域。我们还预测了家族内的单倍型分离情况。
我们在 BMPR2 基因上游 38Mb 的 2q24.3 上确定了一个候选染色体区域,在 PAH 易感性模型下具有显著的连锁(LOD=4.09)。该区域包含与血管发病机制相关的常见变体,并提供了功能证据,表明假定的遗传修饰因子位于 fidgetin(FKBP14)基因的上游远端启动子中。
我们的结果表明,遗传修饰因子通过 转录调控发挥作用,其表达的可变性将有助于调节遗传性 PAH。这一发现可能有助于我们深入了解携带 p.Arg491Gln 致病性突变的家族中 PAH 的外显率降低。